By Admin at 29 Feb 2016
Glioblastoma is the most common type of brain cancer. It’s often aggressive and has a median survival time of under 15 months on average. Researchers are offering new hope for treatment in this area using an unlikely “weapon” – herpes virus.
58
Current Gateway-funded clinical trials
150+
Clinical trials funded at leading institutions worldwide
$16.56
Funds one patient for one day at a Gateway-funded clinical trial
